Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis.

Garrett WS, Gallini CA, Yatsunenko T, Michaud M, DuBois A, Delaney ML, Punit S, Karlsson M, Bry L, Glickman JN, Gordon JI, Onderdonk AB, Glimcher LH.

Cell Host Microbe. 2010 Sep 16;8(3):292-300. doi: 10.1016/j.chom.2010.08.004.

2.

The application of probiotic fermented milks in cancer and intestinal inflammation.

de Moreno de Leblanc A, Perdigón G.

Proc Nutr Soc. 2010 Aug;69(3):421-8. doi: 10.1017/S002966511000159X. Epub 2010 Jun 16.

PMID:
20550747
3.

Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice.

Watterlot L, Rochat T, Sokol H, Cherbuy C, Bouloufa I, Lefèvre F, Gratadoux JJ, Honvo-Hueto E, Chilmonczyk S, Blugeon S, Corthier G, Langella P, Bermúdez-Humarán LG.

Int J Food Microbiol. 2010 Nov 15;144(1):35-41. doi: 10.1016/j.ijfoodmicro.2010.03.037. Epub 2010 Apr 2.

PMID:
20452077
4.

E. coli-mediated gut inflammation in genetically predisposed Crohn's disease patients.

Barnich N, Denizot J, Darfeuille-Michaud A.

Pathol Biol (Paris). 2013 Oct;61(5):e65-9. doi: 10.1016/j.patbio.2010.01.004. Epub 2010 Apr 8. Review.

PMID:
20381273
5.

A human gut microbial gene catalogue established by metagenomic sequencing.

Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J; MetaHIT Consortium, Bork P, Ehrlich SD, Wang J.

Nature. 2010 Mar 4;464(7285):59-65. doi: 10.1038/nature08821.

6.

Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5.

Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, Sitaraman SV, Knight R, Ley RE, Gewirtz AT.

Science. 2010 Apr 9;328(5975):228-31. doi: 10.1126/science.1179721. Epub 2010 Mar 4.

7.
8.

Inflammatory bowel disease.

Kaser A, Zeissig S, Blumberg RS.

Annu Rev Immunol. 2010;28:573-621. doi: 10.1146/annurev-immunol-030409-101225. Review.

9.

Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis.

Hill DA, Hoffmann C, Abt MC, Du Y, Kobuley D, Kirn TJ, Bushman FD, Artis D.

Mucosal Immunol. 2010 Mar;3(2):148-58. doi: 10.1038/mi.2009.132. Epub 2009 Nov 25.

10.

Maintaining diplomatic relations between mammals and beneficial microbial communities.

Hill DA, Artis D.

Sci Signal. 2009 Nov 24;2(98):pe77. doi: 10.1126/scisignal.298pe77.

11.

Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.

Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR.

Nature. 2009 Oct 29;461(7268):1282-6. doi: 10.1038/nature08530.

12.

Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM.

Carvalho FA, Barnich N, Sivignon A, Darcha C, Chan CH, Stanners CP, Darfeuille-Michaud A.

J Exp Med. 2009 Sep 28;206(10):2179-89. doi: 10.1084/jem.20090741. Epub 2009 Sep 8.

13.

Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures.

Salazar N, Ruas-Madiedo P, Kolida S, Collins M, Rastall R, Gibson G, de Los Reyes-Gavilán CG.

Int J Food Microbiol. 2009 Nov 15;135(3):260-7. doi: 10.1016/j.ijfoodmicro.2009.08.017. Epub 2009 Aug 19.

PMID:
19735956
14.

Functional characterization of the antibiotic resistance reservoir in the human microflora.

Sommer MO, Dantas G, Church GM.

Science. 2009 Aug 28;325(5944):1128-31. doi: 10.1126/science.1176950.

15.

A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.

Codling C, O'Mahony L, Shanahan F, Quigley EM, Marchesi JR.

Dig Dis Sci. 2010 Feb;55(2):392-7. doi: 10.1007/s10620-009-0934-x. Epub 2009 Aug 20.

PMID:
19693670
16.
17.

The gut microbiota in inflammatory bowel disease.

Macfarlane GT, Blackett KL, Nakayama T, Steed H, Macfarlane S.

Curr Pharm Des. 2009;15(13):1528-36. Review.

PMID:
19442170
18.

Low counts of Faecalibacterium prausnitzii in colitis microbiota.

Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, Cosnes J, Corthier G, Marteau P, Doré J.

Inflamm Bowel Dis. 2009 Aug;15(8):1183-9. doi: 10.1002/ibd.20903.

PMID:
19235886
19.

Establishment of an analytical system for the human fecal microbiota, based on reverse transcription-quantitative PCR targeting of multicopy rRNA molecules.

Matsuda K, Tsuji H, Asahara T, Matsumoto K, Takada T, Nomoto K.

Appl Environ Microbiol. 2009 Apr;75(7):1961-9. doi: 10.1128/AEM.01843-08. Epub 2009 Feb 5.

20.

Probiotics and immunity.

Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME.

J Gastroenterol. 2009;44(1):26-46. doi: 10.1007/s00535-008-2296-0. Epub 2009 Jan 22. Review.

PMID:
19159071
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk